Enzymatic diagnosis of homocystinuria by determination of cystathionine-ß-synthase activity in plasma using LC-MS/MS
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25218699
DOI
10.1016/j.cca.2014.09.009
PII: S0009-8981(14)00405-7
Knihovny.cz E-zdroje
- Klíčová slova
- Cystathionine ß-synthase activity, Homocystinuria, LC-MS/MS, Pyridoxine response,
- MeSH
- chromatografie kapalinová MeSH
- cystathionin-beta-synthasa krev genetika MeSH
- cystathionin krev MeSH
- dítě MeSH
- dospělí MeSH
- exprese genu MeSH
- genotyp MeSH
- homocystinurie krev diagnóza genetika MeSH
- homozygot MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mutace * MeSH
- předškolní dítě MeSH
- rodokmen MeSH
- senioři MeSH
- tandemová hmotnostní spektrometrie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- cystathionin-beta-synthasa MeSH
- cystathionin MeSH
BACKGROUND: Cystathionine β-synthase (CBS) is released into plasma from organs expressing this enzyme. Decreased plasma CBS activity has been demonstrated in CBS-deficient patients with 16 different genotypes. The aim of this study was to determine plasma CBS activity in patients carrying 11 additional genotypes using two LC-MS/MS methods. Patients and methods CBS activity was measured in EDTA or heparin plasma using either a previously described or a newly developed LC-MS/MS method optimized for analysis of the reaction product, 3,3-(2)H2-cystathionine, as its butyl ester derivative. We analyzed plasma samples from 26 CBS-deficient patients with known genotypes and 57 controls. RESULTS: We developed a new LC-MS/MS method for simple and sensitive determination of CBS activity. Plasma CBS activity was low (i.e., 0.001-0.036 of the multiples of median control values, MoM) in patients homozygous for the prevalent Hispanic mutation c.572C>T (p.T191M) but was highly elevated (2.95 MoM) in a single patient homozygous for the c.1330G>A (p.D444N) mutation. Patients with the remaining nine genotypes exhibited decreased activities (0.00-0.22 MoM), which did not overlap with the controls (0.29-2.10 MoM). CONCLUSIONS: The determination of CBS activity in plasma is a rapid and non-invasive procedure for detecting a subgroup of CBS-deficient patients with distinct genotypes.
Citace poskytuje Crossref.org
Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria
A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
